thought call
remain focu ahead strong commerci execut despit alexion strong
perform reminisc previou beat-and-rais
phasew think investor remain focus ahead like first approv
pnh commerci oper didnt impress though admittedli
benefit one-tim item fx tailwind juli holiday pre-
order alexion report continu strong uptak core indic pnh
ahu support complet ahu studi enrol
gmg launch gain signific momentum us patient therapi vs
strensiq perform also pleasant surpris acceler growth lead
sale guidanc gmg help drive soliri sale near-
termminu temporari headwind studi set start
continu look provid next leg growth alexion
improv patient profil extend ip protect encourag
alexion plan grow franchis via new indic plan ahu file
gmg earli new formul multipl sq reduc infus
time company-produc market research indic physician likelihood
switch patient togeth improv pipelin includ
complement pharma collabor littl threat biosimilar competit
continu like alexion stori top pick reiter ow pt
pipelin updat japan pnh regulatori submiss track
alexion updat phase power superior ad liver
biopsi studi provid differenti expect file
nmosd prevent soliri complet data read-out track
model chang reduc soliri forecast includ gmg
studi off-set strensiq result top-lin increas
respect adjust opex number reflect guidanc
estim non-gaap ep respect vs prior
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
growth soliri pnh/ahu growth driven
sale refractori gmg assum
approv extend dose option
pnh ahu support long-term
viabil complement franchis recent fx
improv
greater expect growth soliri current
indic ahu pnh gmg label
expans soliri nmo posit data
rapid uptak iv
subcutan formul support upsid case
biosimilar competit soliri
time frame high price pressur ww
geographi addit failur
pnh ahu increas fx headwind
macroeconom issu support downsid case
except per op analysisoldnewoldnewr barclay
geoff meacham ph herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
